ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,828Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1290

$579K Total Retail Price of All Prescriptions

Rank: 156 out of 1290

360 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,174 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ATORVASTATIN CALCIUM 311 295 1 23
OMEPRAZOLE 306 267 2 2
LISINOPRIL 290 264 3 5
SIMVASTATIN 279 265 4 1
LEVOTHYROXINE SODIUM 248 219 5 4
CRESTOR 187 161 6 17
METFORMIN HCL 185 178 7 10
METOPROLOL SUCCINATE 184 167 8 14
AMLODIPINE BESYLATE 178 170 9 3
ZOLPIDEM TARTRATE 178 143 9 15
ALPRAZOLAM 152 150 11 47
DIOVAN HCT 142 140 12 112
ATENOLOL 141 129 13 18
LOSARTAN POTASSIUM 129 118 14 19
SERTRALINE HCL 122 114 15 36
DONEPEZIL HCL 122 122 15 13
CLOPIDOGREL 115 109 17 24
TEMAZEPAM 114 114 18 71
PLAVIX 112 110 19 32
DIOVAN 110 110 20 53
PANTOPRAZOLE SODIUM 107 99 21 48
METOPROLOL TARTRATE 102 101 22 7
RANITIDINE HCL 99 91 23 49
HYDROCHLOROTHIAZIDE 89 87 24 20
TAMSULOSIN HCL 84 76 25 11
SYNTHROID 78 65 26 28
ALLOPURINOL 71 70 27 60
FUROSEMIDE 70 70 28 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 67 29 92
SINGULAIR 68 64 30 85
CLOTRIMAZOLE-BETAMETHASONE 68 63 30 153
CIALIS 65 64 32 230
CARVEDILOL 63 63 33 12
MICARDIS 62 57 34 439
FENOFIBRATE 61 60 35 98
AZITHROMYCIN 61 56 35 61
NEXIUM 60 60 37 34
ESCITALOPRAM OXALATE 55 38 38 63
NAPROXEN 54 48 39 115
CELEBREX 54 53 39 111
IBUPROFEN 52 38 41 74
VOLTAREN 51 48 42 107
KOMBIGLYZE XR 51 44 42 525
CITALOPRAM HBR 51 48 42 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.